Book a Meeting

What Will Our PBM Have to Disclose Under DOL’s New Rule, and Does It Apply to Our Self-Funded or Level-Funded Plan?

In this article

The Department of Labor (DOL) has finalized what pharmacy benefit managers (PBMs) must disclose to employer health plans. PBM contracts renewed in 2027 set the terms for the first covered plan year for most calendar-year plans.

The short answer

Yes, if your plan is self-funded or level-funded and your company averaged at least 100 employees last calendar year. For plan years beginning on or after July 1, 2027, your PBM or the entity that contracts for PBM services must disclose expected compensation before it signs or renews, report actual pay twice a year, and allow an annual audit. Fully insured and smaller plans still get statutory ERISA 408(b)(2)(B) disclosures.

Does the rule apply to our plan?

It applies if the plan is not fully insured and passes a size test. The final rule, FR Doc 2026-22306 (91 FR 69092) sets two tests:

  1. Single-employer plans: covered if the employer averaged at least 100 employees on business days in the preceding calendar year. Employees are counted, and related companies aggregated, under the Affordable Care Act employer-mandate rules in Internal Revenue Code section 4980H.
  2. Union and multiemployer-type plans: covered if the plan averaged at least 100 participants, not counting beneficiaries, in the preceding plan year.
  3. Excluded: fully insured plans, and plans of sponsors that are, or are affiliated with, drug manufacturers, distributors, wholesalers, PBMs or rebate aggregators.

The rule’s preamble treats level-funded arrangements as self-funded, so they are not excluded. The covered service provider is whoever contracts to provide PBM services, often the level-funded program administrator, even if it subcontracts. In self-funded and ASO plans, carve-out and bundled PBM contracts both count.

A covered service provider is one that reasonably expects $1,000 or more in direct or indirect compensation.

When does the rule take effect for a calendar-year plan?

The final rule is effective January 4, 2027, and applies to plan years beginning on or after July 1, 2027.

For a calendar-year plan, our reading is that the first covered plan year begins January 1, 2028. The rule does not state that date; it is our application of the July 1, 2027 trigger.

The initial disclosure must come reasonably in advance of a contract, extension or renewal, and 90 calendar days is deemed reasonable for renewals. The rule does not say whether the first disclosure must precede the first covered plan year, so treat 90 days as a request, not a deadline.

Until the rule applies, under DOL’s temporary enforcement policy, DOL will not treat a provider as having failed to disclose if it made disclosures based on a good-faith reading of section 408(b)(2)(B), and will not treat a plan fiduciary as having engaged in a prohibited transaction if it acted on a good-faith reading of its duty to judge reasonableness. It runs from February 3, 2026 to the applicability date, which depends on each plan’s year.

What does the PBM have to disclose?

Before it signs, extends or renews, the covered service provider must give the plan fiduciary a written disclosure covering:

  1. Expected direct compensation from the plan or sponsor, by service and in total, allocated across bundled services.
  2. Manufacturer payments, including rebates, fees and discounts, in total and per drug, split between amounts passed through and amounts retained.
  3. Spread compensation by drug and pharmacy channel, plus any steering to affiliated pharmacies.
  4. Pharmacy recoupments, including copay claw-backs, with the expected number of transactions.
  5. Price-protection agreements, passed through versus retained.
  6. Formulary placement incentives and any retained right to change the formulary mid-term, with advance notice of changes that, individually or in the aggregate, are reasonably expected to have a material impact: 5% or more of aggregate manufacturer-payment compensation, or a lower percentage or dollar amount the parties agree to in writing.
  7. Net price per drug after rebates and fees, its fiduciary status if any, and a statement of the plan’s audit right.

After that, the provider reports actual compensation every 6 months, or quarterly on request, within 30 calendar days after each period, and explains any category running 5% or more over the estimate.

Disclosures must be stated in dollars, with a machine-readable file on request, and the provider cannot restrict how the plan uses them. A good-faith error or omission, made with reasonable diligence, does not cause the contract to fail the reasonableness condition if it is corrected as soon as practicable, and not later than 30 calendar days from the date the provider knows of it.

Can we audit our PBM, and who pays?

Yes. Under the final rule, the plan can audit at least once a year on written request and choose its own auditor. The provider confirms receipt within 10 business days and provides the information within 60 calendar days.

The plan pays its auditor, and the provider bears the cost of producing the data, including its pharmacy, manufacturer and rebate-aggregator contracts.

What happens if our PBM doesn’t provide the required disclosures?

A provider that fails to disclose is in a prohibited transaction, absent another exemption, and DOL may, at its discretion, assess a civil penalty under ERISA section 502(i). The plan fiduciary is protected by the rule’s class exemption if it did not know of the failure, reasonably believed the rules were met, and follows these steps:

  1. On discovering the failure, ask the provider in writing to correct it.
  2. Wait up to 90 calendar days for the provider to comply.
  3. Notify DOL within 30 calendar days after the earlier of the provider’s refusal or day 90, as DOL’s instructions direct.
  4. Decide, as a prudent fiduciary, whether to end or continue the contract, and document why. The rule does not require termination.

What if our plan is fully insured or under 100 employees?

The detailed rule does not apply, but statutory disclosure does. As the rule’s preamble explains, the Consolidated Appropriations Act, 2026 (CAA 2026) extended ERISA section 408(b)(2)(B), effective February 3, 2026, to PBMs, third-party administrators (TPAs) and other providers, alongside brokers and consultants.

Any of them expecting $1,000 or more must disclose compensation reasonably in advance of the contract or renewal, and must disclose changes as soon as practicable, and no later than 60 days after it is informed of the change. A PBM contracting with the insurer of a fully insured plan is now a party in interest to that plan.

What changes in 2028?

For plan years beginning on or after August 3, 2028, CAA 2026 requires providers of PBM services to remit to the plan (or the insurer on the plan’s behalf) 100% of rebates, fees, alternative discounts, and other remuneration from applicable entities related to drug utilization or spending, with bona fide, transparent service fees still allowed, and adds ERISA section 726 PBM reports every 6 months, as the final rule’s preamble summarizes them. The semiannual section 726 report is required for self-insured plans of employers with 100 or more employees, and fully insured plans of that size can opt in.

A timeline for a calendar-year plan

January 4, 2027 and July 1, 2027 are set by the rule. August 3, 2028 is a CAA date as the preamble summarizes it. The calendar-year working dates below are computed from the July 1, 2027 trigger; January 1, 2028 is our reading, not a date DOL states. Our ERISA compliance hub covers the related rules.

Date What happens Source
Jan 4, 2027 Rule takes effect FR Doc 2026-22306
Jul 1, 2027 First plan years in scope FR Doc 2026-22306
Oct 3, 2027 90 days before a Jan 1, 2028 renewal: deemed-reasonable initial disclosure date Computed from 29 CFR 2550.408b-22(e) and (p)(2); 90 days is deemed reasonable, not a deadline the rule sets for the first covered plan year. See FR Doc 2026-22306
Jan 1, 2028 First covered plan year for calendar-year plans (our reading) Our application of 29 CFR 2550.408b-22(p)(2); the rule does not state this date. See FR Doc 2026-22306
Plan years on or after Aug 3, 2028 Rebate pass-through and section 726 reports begin FR Doc 2026-22306

If your renewal is already signed, see what a locked renewal still lets you change.

The rule does not make a PBM contract reasonable. It gives you the numbers to judge it, so set the review process and contract terms before the first disclosure arrives.

What this means at 50–99, 100–499, and 500+ employees

Employer size What applies
50–99 Outside the detailed rule. Statutory 408(b)(2)(B) disclosures apply now. Related companies count together, so a group near 100 should confirm its average each year.
100–499 Self-funded and level-funded plans are in scope from the first plan year beginning on or after July 1, 2027. Fully insured plans get the statutory disclosure only.
500+ Same rule. Drug-level data and machine-readable files matter most for plans that can analyze them or fund an audit.

Next steps

  1. HR and Finance, within 30 days: confirm whether the plan is fully insured, level-funded or self-funded, and confirm last calendar year’s average employee count, with related companies aggregated.
  2. HR, before your next renewal: if you are under 100 employees or fully insured, request the statutory compensation disclosure from every broker, consultant, TPA and PBM.
  3. Finance, by Q1 2027: identify the covered service provider that signs for PBM services, find the PBM contract’s renewal date, and calendar the 90-day initial disclosure request.
  4. Plan committee, by Q2 2027: name the fiduciary who reviews disclosures and document how it judges reasonableness.
  5. Your benefits broker, about 150 days before the first covered plan year: write the disclosure, reporting, audit and unrestricted-use terms into the renewal or RFP.
  6. Finance, after each semiannual report: compare actuals with estimates, flag overages of 5% or more, and decide on the annual audit.

Frequently asked questions

What are the new PBM fee disclosure rules for employer health plans?

DOL’s final rule requires PBMs serving self-funded and level-funded plans of employers that averaged at least 100 employees last calendar year to disclose their compensation, for plan years beginning on or after July 1, 2027. Disclosure comes before the contract is signed or renewed. Reports follow every 6 months, or quarterly, and the plan can audit once a year.

Does the DOL PBM fee disclosure rule apply to level-funded plans?

Yes, if the employer averaged at least 100 employees last calendar year. The final rule treats level-funded plans as self-funded.

Does the PBM disclosure rule apply to fully insured plans?

No. Plans whose benefits are all provided through insurance are not covered plans under the final rule. Their providers still owe the statutory 408(b)(2)(B) compensation disclosure.

When does the PBM fee disclosure rule take effect for a calendar-year plan?

Plan years beginning on or after July 1, 2027, per the Federal Register. For a calendar-year plan, we read that as January 1, 2028; DOL does not state that date.

Victor Morgan, a licensed agent and independent benefits broker, is individually licensed in 30 states and reviews PBM contract terms with employers at renewal. See our employee group health insurance services.

Use the button below to book a free 20-minute benefits review.

This article is general information for employers and is not legal, tax, or accounting advice. Confirm requirements with counsel and your plan documents.

By Victor Insures You Editorial Team | Reviewed by Victor Morgan, Licensed Agent and Independent Benefits Broker
Victor Insures You LLC, Texas Agency License #2443871 | Victor Morgan, Texas License #1939462
Published November 16, 2026 | Last reviewed November 16, 2026